期刊文献+

2型糖尿病患者血小板膜糖蛋白Ib/IX/V复合物表达的研究 被引量:2

Expression of Platelet Glycoprotein Ib/IX/V Complex in Patients with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的观察2型糖尿病(T2DM)患者血小板膜糖蛋白(GP)Ib/IX/V复合物及其组分GPIbα的表达。方法将51例T2DM患者分为控制良好组(WCP组)和控制不良组(PCP组),并根据有无血管病变分为伴血管病变组(VD组)和不伴血管病变组(NVD组)。同时选取23例健康体检者为正常对照组(NC组)。检测受试者的生化指标、血小板GPIb/IX/V复合物和GPIbα的表达,并采用比浊法检测血小板最大聚集率(MA)。结果(1)PCP组空腹血糖(FPG)和糖化血红蛋白(HbA1c)与NC组、WCP组比较,差别有统计学意义(P<0.01);WCP组和PCP组的空腹胰岛素(FINS)、BMI、血脂(TC、TG、HDL、LDL)与NC组比较,差别有统计学意义(P<0.01)。(2)WCP组、PCP组GPⅠb/Ⅸ/Ⅴ复合物平均荧光强度(MFI)与NC组比较,差别有统计学意义(P<0.05);且PCP组GPⅠb/Ⅸ/Ⅴ复合物的MFI与WCP组比较,差别亦有统计学意义(P<0.05)。WCP组、PCP组GPⅠbαMFI与NC组比较,差别有统计学意义(P<0.01);且PCP组GPⅠbαMFI与WCP组比较,差别亦有统计学意义(P<0.01)。(3)相关性分析显示,T2DM患者GPⅠb/Ⅸ/Ⅴ复合物的MFI与FPG、HbA1c、FINS呈负相关(P<0.05);GPⅠbαMFI与FBG、HbA1c呈负相关(P<0.05)。结论T2DM患者不伴血管病变时即存在血小板活化,发生血管病变后活化更明显,且血小板活化与血糖呈正相关。血小板GPⅠb/Ⅸ/Ⅴ复合物作为凝血酶和血管性血友病因子的受体,可能参与了T2DM血管病变的发生、发展。 Objective To investigate the expression of platelet membrane glycoprotein (GP) Ⅰb/Ⅸ/Ⅴ complex and its constituent GP Ibedn patients with type 2 diabetes mellitus (T2DM). Methods 51 T2DM patients were assigned to a well - controlled (WC) group and a poorly - controlled (PC) group, meanwhile they were divided into a vascular disease (VD) group and a non -vascular disease (NVD) group according to status of vascular lesion, and 23 normal subjects were chosen as the normal control (NC) group. The expressions of platelet GP Ⅰb/Ⅸ/Ⅴ complex and GP Ibetwere determined by flow cytometry, and platelet maximum agglutination (MA) by turbidity method. Results Compared with healthy subjects, the expressions of GP Ⅰb/Ⅸ/Ⅴ complex, GP Ibαin T2DM patients were significantly decreased ( P 〈0. 05 ), and platelet MA were remarkably increased ( P 〈0. 05). The expressions of GP Ⅰb/Ⅸ/Ⅴ complex, GP Ibetwere respectively lower in PCP and VD group than in WCP and NVD group ( P 〈 0. 05), and platelet MA were respectively higher in PCP and VD group than in WCP and NVD group ( P 〈 0. 05 ). The expressions of GP Ibαand GP Ⅰb/Ⅸ/Ⅴ complex were markedly negatively correlated to fast plasma glucose and glycosylated hemoglobin ( P 〈0. 05). Conclusion Existing in the early stage of T2DM without diabetic angiopathies, platelet acti- vation is more obvious after diabetic angiopathies, and is positively correlated to blood glucose. As a receptor of thrombin and von Willebrand Factor, GP Ⅰb/Ⅸ/Ⅴ complex may contribute to the development of angiopathy in T2DM.
出处 《中国全科医学》 CAS CSCD 2008年第6期470-473,共4页 Chinese General Practice
关键词 血小板膜糖蛋白类 糖尿病 2型 糖尿病血管病变 血小板聚集 Platelet membrane glycoproteins Diabetes mellitus, type 2 Diabetic angiopathies Platelet aggregation
  • 相关文献

参考文献18

  • 1Nesto RW. Correlation between cardiovascular disease and diabetes mellitus: current concepts [J]. Am J Med, 2004, 116 (Suppl): 11S - 22S.
  • 2Ferroni P, Basili S, Falco A, et al. Platelet activation in type 2 diabetes mellitus [J]. J Thromb Haemost, 2004, 2 (8) : 1282 -1291.
  • 3Ouvina SM, La Greca RD, Zanaro NL, et al. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type Ⅱ patients [J]. Thromb Res, 2001, 102 (2) : 107 -114.
  • 4Escolar G, White JG. Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies [J]. Thromb Haemost, 2000, 83 (3): 371-386.
  • 5Shen Y, Romo GM, Dong JF, et al. Requirement of leucine - rich repeats of glycoprotein ( GP ) Ibalpha for shear - dependent and static binding of yon Willebrand factor to the platelet membrane GP Ib - IX - V complex [J]. Blood, 2000, 95 (3): 903-910.
  • 6Roth GL. A new kid on the platelet thrombin receptor block : GlycoproteinIb-IX-V [J]. PNAS, 2001, 98, 1330-1331.
  • 7黄葆钧 余斌杰.糖尿病肾病的诊断与症治[J].中华医学杂志,1984,64:160-163.
  • 8Linden MD, Frelinger AL, Barnard MR, et al. Application of flow cytometry to platelet disorders [J]. Semin Thromb Hemost, 2004, 30 (5) : 501 -511.
  • 9Yngen M, Ostenson CG, Hu H, et al. Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation [J]. Diabetologia, 2004, 47 (3): 537-540.
  • 10SZ Luo, X Mo, V Afshar - Kharghan, et al. Glycoprotein Ibα forms disulfide bonds with 2 glycoprotein Ib? subunits in the resting platelet [J]. Blood, 2007, 109 (2): 603-609.

二级参考文献5

  • 1Kessler L,Wiesel ML, Attali P,et al. von Willebrand factor in diabetic angiopathy. Diabetes Metab, 1998,24:327-336.
  • 2Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roent Genol, 1982,138: 565-570.
  • 3Fioretto P, Stehouwer CD, Mauer M, et al. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia, 1998,41:233-236.
  • 4Hirano T, Ookubo K, Kashiwazaki K, et al. Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy. Clin Chim Acta, 2000,299:65-75.
  • 5Stehouwer CD, Fischer HR, van Kuijk AW, et al. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes, 1995,44:561-564.

共引文献6

同被引文献12

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部